Measurement of insulin-mediated glucose uptake: Direct comparison of the modified insulin suppression test and the euglycemic, hyperinsulinemic clamp

Metabolism: Clinical and Experimental

Volumn 62, Issue 4, 2013, Pages 548-553

  Knowles, Joshua W ^a   Assimes, Themistocles L ^a   Tsao, Philip S ^a   Natali, Andrea ^b   Mari, Andrea ^c   Quertermous, Thomas ^a   Reaven, Gerald M ^a   Abbasi, Fahim ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PISA   (Italy)

^c CNR   (Italy)

Author keywords

Euglycemic hyperinsulinemic clamp; Insulin resistance; Insulin suppression test

Indexed keywords

GLUCOSE; INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; EUGLYCEMIC HYPERINSULINEMIC CLAMP; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SUPPRESSION TEST; MALE; PRIORITY JOURNAL;

ADULT; AGED; BLOOD GLUCOSE; FEMALE; GASTROINTESTINAL AGENTS; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OCTREOTIDE; REGRESSION ANALYSIS;

EID: 84884211524     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2012.10.002     Document Type: Article

References (20)

1. G.M. Reaven The fourth musketeer - from Alexandre Dumas to Claude Bernard Diabetologia 38 1995 3 13
2. H. Yeni-Komshian, M. Carantoni, F. Abbasi, and G.M. Reaven Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers Diabetes Care 23 2000 171 175
3. F.S. Facchini, N. Hua, F. Abbasi, and G.M. Reaven Insulin resistance as a predictor of age-related diseases J Clin Endocrinol Metab 86 2001 3574 3578
4. J. Yip, F.S. Facchini, and G.M. Reaven Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease J Clin Endocrinol Metab 83 1998 2773 2776
5. G.M. Reaven The insulin resistance syndrome Curr Atheroscler Rep 5 2003 364 371
6. G.M. Reaven Why syndrome X? From Harold Himsworth to the insulin resistance syndrome Cell Metab 1 2005 9 14
7. G.M. Reaven, and B.B. Hoffman Hypertension as a disease of carbohydrate and lipoprotein metabolism Am J Med 87 1989 2S 6S
8. M.S. Greenfield, L. Doberne, F. Kraemer, T. Tobey, and G. Reaven Assessment of insulin resistance with the insulin suppression test and the euglycemic clamp Diabetes 30 1981 387 392
9. S.W. Shen, G.M. Reaven, and J.W. Farquhar Comparison of impedance to insulin-mediated glucose uptake in normal subjects and in subjects with latent diabetes J Clin Invest 49 1970 2151 2160
10. D. Pei, C.N. Jones, R. Bhargava, Y.D. Chen, and G.M. Reaven Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test Diabetologia 37 1994 843 845
11. A. Mimura, S. Kageyama, M. Maruyama, Y. Ikeda, and Y. Isogai Insulin sensitivity test using a somatostatin analogue, octreotide (Sandostatin) Horm Metab Res 26 1994 184 187
12. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 35 Suppl 1 2012 S64 S71
13. R.A. DeFronzo, J.D. Tobin, and R. Andres Glucose clamp technique: a method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 E223
14. S.A. Hills, B. Balkau, S.W. Coppack, J.M. Dekker, A. Mari, A. Natali, M. Walker, and E. Ferrannini The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I Methodology and objectives Diabetologia 47 2004 566 570
15. J. Andrews, I. Klimes, B. Vasquez, M. Nagulesparan, and G.M. Reaven Can mixed venous blood be used to measure insulin action during the hyperinsulinemic clamp? Horm Metab Res 16 Suppl 1 1984 164 166
16. P.E. Watson, I.D. Watson, and R.D. Batt Total body water volumes for adult males and females estimated from simple anthropometric measurements Am J Clin Nutr 33 1980 27 39
17. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
18. C. Conte, E. Fabbrini, M. Kars, B. Mittendorfer, B.W. Patterson, and S. Klein Multiorgan insulin sensitivity in lean and obese subjects Diabetes Care 35 2012 1316 1321
19. W.H. Sheu, C.B. Hollenbeck, M.S. Wu, J.B. Jaspan, Y.D. Chen, and G.M. Reaven Effect of difference in glucose infusion rate on quantification of hepatic glucose production J Clin Endocrinol Metab 70 1990 1354 1360
20. E. Ferrannini, S. Camastra, S.W. Coppack, D. Fliser, A. Golay, and A. Mitrakou Insulin action and non-esterified fatty acids. The European Group for the Study of Insulin Resistance (EGIR) Proc Nutr Soc 56 1997 753 761